American biotechnologists have, for the first time, restored youthful characteristics in aged human liver cells using epigenetic reprogramming. The company is preparing for clinical trials to confirm the effectiveness of this method and to expand its use for treating liver diseases and rejuvenating other tissues.
Engineers at MIT have developed a method for introducing liver cells encapsulated in protective gel particles, enabling the formation of mini-organs directly inside the body. This technology could reduce the need for liver transplants and provide support for patients with chronic liver failure.
For the first time, the technology of epigenetic cell rejuvenation, previously tested successfully on animals, is moving into clinical trials in humans. The new drug ER-100 could pave the way for restoring retinal cell function and treating age-related eye diseases.
A new study has revealed a link between depression and disruptions in energy processes within brain and blood cells. These findings could aid in early diagnosis and the development of more effective treatment methods.
For the first time in Israel, doctors have successfully transplanted a cornea printed on a 3D printer, restoring a patient's vision. This technology has the potential to solve the shortage of donor tissues and revolutionize the treatment of blindness.
Salus
